Skip to main content
2026 CRT Conference Main banner

CRT 2026

Early Career Leader Symposium

Session:: Early Career Leader Roundtable [Non-CME; Invitation Only] – Sponsored by Medtronic

Breakout Group Discussion | Networking & Mentorship

Monday, March 9, 2026
7:00 PM - 7:25 PM EST
Location: Lincoln

    Facilitator(s)

  • Jaffar M. Khan, MD, PhD

    Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
    St Francis Hospital and Heart Center
    Roslyn, New York, United States

    Disclosure(s): Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Cuspa Medical: Stock Options [in privately held companies] (Ongoing)

  • Jason Fontana, PhD

    VP/GM Renal Denervation
    Medtronic
    San Diego, California, United States

    Disclosure(s): Medtronic: Employee (Ongoing)

  • Paul D. Mahoney, MD, FACC, FSCAI

    Chief, Interventional Cardiology, Director, Structural Heart Program
    ECU Health
    Greenville, North Carolina, United States

    Disclosure information not submitted.

  • Jorie S. Soskin

    Vice President, Structural Heart
    Medtronic
    Mounds View, Minnesota, United States

    Disclosure(s): medtronic.: Employee (Ongoing)

    • Roundtable Participant(s)

  • Seyed Hossein Aalaei-Andabili, MD

    Faculty, structural and interventional cardiology
    University of Maryland
    Baltimore, Maryland, United States

    Disclosure(s): No financial relationships to disclose

  • Jung-Joon Cha, MD

    Clinial Associate Professor
    Korea University Anam Hospital
    Seoul, Seoul-t'ukpyolsi, Republic of Korea

    Disclosure(s): Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Yuvraj Chowdhury, MD FACC FCSAI

    Director Cardiac Cath Lab, University Hospital
    Univeristy of Louisville
    Louisville, Kentucky, United States

    Disclosure(s): No financial relationships to disclose

  • Marcos Garcia-Guimaraes, MD PhD

    Interventional Cardiologist
    Hospital Universitario de Cabueñes, Gijon, Spain
    Gijon, Spain

    Disclosure(s): No financial relationships to disclose

  • Cynthia N. Jackson Pedroza

    Interventional Cardiologist
    Instituto Nacional de Enfermedades Respitratorias
    Mexico City, Mexico

    Disclosure(s): No financial relationships to disclose

  • Arvind Kalyan Sundaram, MD, FACC, FSCAI

    Interventional Cardiologist
    Carle Bromenn Medical Center

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Eli Lilly & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

  • Kameel Kassab, MD

    Interventional Cardiologist
    Yuma Medical Center/ Onvida Health
    Yuma, Arizona, United States

    Disclosure(s): No financial relationships to disclose

  • Mohammad A. Kawsara, MD

    Director, Structural Heart Disease Program
    Methodist Dallas Medical Center
    Dallas, Texas, United States

    Disclosure(s): No financial relationships to disclose

  • Thomas Nestelberger, PD Dr.

    Head of Structural Cardiology
    University Hospital Basel

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Meril, Pronova Medical, Edwards, Abbot, Medtronic, Innova HTS,: Grant/Research Support (Ongoing)

  • Nazli Okumus, MD

    Interventional/Structural Cardiologist
    CVI Central Florida

    Disclosure(s): No financial relationships to disclose

  • Hitesh Raheja, MD, FACC, FSCAI

    Structural Heart Director
    St. Mary Medical Center
    Cherry Hill, New Jersey, United States

    Disclosure(s): No financial relationships to disclose

  • Sumon Roy, MD

    Interventional & Structural Cardiologist
    Boston Medical Center, United States

    Disclosure(s): No financial relationships to disclose

  • Hao-Yu Wang, MD, PhD

    Associate Professor, Department of Cardiology, Coronary Heart Disease Center
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
    Beijing, Beijing, China (People's Republic)

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Cuspa Medical: Stock Options [in privately held companies] (Ongoing)
Jason Fontana, PhD: Medtronic: Employee (Ongoing)
Jorie S. Soskin: medtronic.: Employee (Ongoing)
Seyed Hossein Aalaei-Andabili, MD: No financial relationships to disclose
Jung-Joon Cha, MD: Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Yuvraj Chowdhury, MD FACC FCSAI: No financial relationships to disclose
Marcos Garcia-Guimaraes, MD PhD: No financial relationships to disclose
Cynthia N. Jackson Pedroza: No financial relationships to disclose
Arvind Kalyan Sundaram, MD, FACC, FSCAI: Abbott Vascular, Medtronic, Boston Scientific: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Eli Lilly & Company: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Kameel Kassab, MD: No financial relationships to disclose
Mohammad A. Kawsara, MD: No financial relationships to disclose
Thomas Nestelberger, PD Dr.: Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Meril, Pronova Medical, Edwards, Abbot, Medtronic, Innova HTS,: Grant/Research Support (Ongoing)
Nazli Okumus, MD: No financial relationships to disclose
Hitesh Raheja, MD, FACC, FSCAI: No financial relationships to disclose
Sumon Roy, MD: No financial relationships to disclose
Hao-Yu Wang, MD, PhD: No financial relationships to disclose